cell cell
Steffan Crausaz BPharm, MSc, MBA, MRPharmS
Chief Executive, PHARMAC, Wellington, NZ


Steffan was appointed Chief Executive of PHARMAC in July 2012. Prior to taking up the CE position in an interim capacity in 2011, Steffan was Manager of Funding and Procurement, leading PHARMAC’s commercial and health technology assessment activities.

Before joining PHARMAC in 2003, Steffan trained as a pharmacist in the UK. A graduate of Cardiff University, he also worked in the pharmaceutical industry (branded and generic) while undertaking his Masters in pharmacoeconomics and pharmaceutical policy. In the intervening years he also attained his MBA from the University of Sydney.

Steffan lives in Wellington with his wife and three children.



PHARMAC: Delivering Value from Medical Devices

Medical devices are an important, and integrated, part of our health system. They offer an opportunity to improve health outcomes for our patients and to create efficiencies for the system that cares for them.

There has been a long-standing vision for PHARMAC to take on a more central role in optimising the factors that lead to the benefits from medical devices being more fully adopted.

A number of important milestones have been reached and PHARMAC’s activity is now accelerating as a result of the capabilities that have been established, and supported by the new DHB procurement strategy. The strategy strengthens PHARMAC’s partnership with DHBs, to assist delivery the full expected benefits.

What are the next stops on the journey, and how will we know if the destination is what was hoped for?